Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: Comparative analysis from Brazil, India, and South Africa

Vaccine

Volumn 29, Issue 5, 2011, Pages 969-975

  Griffiths, Ulla K ^a   Santos, Andreia C ^a   Nundy, Neeti ^b   Jacoby, Erica ^b   Matthias, Dipika ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PATH   (United States)

Author keywords

Brazil; Costs; India; Jet injector; South Africa; Vaccine

Indexed keywords

HEPATITIS B VACCINE; YELLOW FEVER VACCINE;

ARTICLE; BRAZIL; COMPARATIVE STUDY; COST; DRUG DELIVERY SYSTEM; INDIA; JET INJECTION; JET INJECTOR; PRIORITY JOURNAL; SOUTH AFRICA; VACCINATION;

BRAZIL; CHILD; CHILD, PRESCHOOL; HEALTH CARE COSTS; HUMANS; INDIA; INFANT; INFANT, NEWBORN; INJECTIONS, JET; SOUTH AFRICA; VACCINATION;

EID: 78751621003     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.038     Document Type: Article

References (28)

1. WHO Safety of injections, global facts and figures 2004, WHO, Geneva.
2. Hauri A.M., Armstrong G.L., Hutin Y.J. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004, 15(1):7-16.
3. Pruss-Ustun A., Rapiti E., Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005, 48(6):482-490.
4. Dicko M., Oni A.Q., Ganivet S., Kone S., Pierre L., Jacquet B. Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ 2000, 78(2):163-169.
5. Tamplin S.A., Davidson D., Powis B., O'Leary Z. Issues and options for the safe destruction and disposal of used injection materials. Waste Manag 2005, 25(6):655-665.
6. Royal College of Paediatrics and Child Health, Position Statement on Injection Technique, London,; 2002. http://www.rcn.org.uk/__data/assets/pdf_file/0010/78535/001753.pdf.
7. WHO BCG vaccine. WHO position paper. Wkly Epidemiol Rec 2004, 4(79):25-40.
8. Stout R.R., Gutierrez M.J., Freeland P.J., Fein M., Taylor D., Davis Y., et al. Needle-free injections using a spring-powered device for subcutaneous, intramuscular and intradermal injections. Drug Deliv Technol 2007, 7(2):40-43.
9. Giudice E.L., Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 2006, 58(1):68-89.
10. OPTIMIZE Landscape analysis. Trends in vaccine availability and novel vaccine delivery technologies: 2008-2025 2008, WHO.
11. WHO, Intradermal delivery of vaccines, WHO-PATH; 2009. Available at http://www.who.int/immunization_delivery/systems_policy/Intradermal-deli very-vaccines_report_2009-Sept.pdf.
12. Lambert P.H., Laurent P.E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008, 26(26):3197-3208.
13. Roukens A.H., Vossen A.C., Bredenbeek P.J., van Dissel J.T., Visser L.G. Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS ONE 2008, 3(4).
14. PATH and WHO Intradermal delivery of vaccines: a review of the literature and the potential for development for use in low- and middle-income countries 2009, PATH and WHO, Ferney Voltaire, France. http://www.path.org/files/TS_opt_idd_review.pdf.
15. Sangare L., Manhart L., Zehrung D., Wang C.C. Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine 2009, 27(12):1777-1786.
16. Kou U. Guidelines for estimating costs of introducing new vaccines into the national immunization system 2002, WHO, Geneva.
17. Walker D., Kumaranayake L. Allowing for differential timing in cost analyses: discounting and annualization. Health Policy Plan 2002, 17(1):112-118.
18. Ministerio da Saude Diretrizes Metodológicas, Estudos de Avaliação Econômica de Tecnologias em Saúde 2009, Ministerio da Saude, Brasilia. http://bvsms.saude.gov.br/bvs/publicacoes/avaliacao_economica_tecnologia s_saude_2009.pdf.
19. New Jersey Health Officers Association Mass vaccination exercises: best practices report. With lessons learned from City of Paterson, Gloucester County, Morris County, Monmouth County and Montgomery Township 2009.
20. Light D.W., Andrus J.K., Warburton R.N. Estimated research and development costs of rotavirus vaccines. Vaccine 2009, 27(47):6627-6633.
21. Eberle J., Allain L., Nersesian P. Logistics of health care waste management: information and approaches for developing country settings 2009, T.O. USAID DELIVER PROJECT, Arlington, VA, March.
22. WHO WHO best practices for injections and related procedures toolkit 2002, WHO, Geneva.
23. WHO Vaccine vial monitor and opened vial policy 1996, WHO, Geneva.
24. WHO Regional Office for South East Asia (SEARO) Bio medical sharps waste management in India: evaluating alternative treatment and non-burn disposal practices. Review of 12 case studies 2004, D.o.I.a.V.D.a.D.o.S.D.a.H. Environment, New Delhi.
25. Ministry of Health and Family Welfare Operating cost of immunization programmes 2008, Ministry of Health and Family Welfare. http://mohfw.nic.in/NRHM/PIP_09_10/AP/Immunization_Text.pdf.
26. Griffiths U.K., Botham L., Schoub B.D. The cost-effectiveness of alternative polio immunization policies in South Africa. Vaccine 2006, 24(29-30):5670-5678.
27. Guichard S., Hymbaugh K., Burkholder B., Diorditsa S., Navarro C., Ahmed S., et al. Vaccine wastage in Bangladesh. Vaccine 2010, 28(3):858-863.
28. Ekwueme D.U., Weniger B.G., Chen R.T. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull World Health Organ 2002, 80(11):859-870.